The FDA is expected to grant approval to a new pain medication with big potential—mainly because it's a non-opioid and is ...

Part of that involves looking at the #fundamentals, but half of the disclosure comes from looking at price action.

We recently compiled a list of the Blackrock’s 30 Most Important AI Stocks. In this article, we are going to take a look at ...

Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have such strong ...